Operator

Hello, and welcome to the 10x Genomics Inc. Annual Meeting of Stockholders. Please note that this meeting is being recorded. [Operator Instructions].

Serge Saxonov
Co-Founder, CEO & Director

Good afternoon. It is a pleasure to welcome all of you to the 2026 Annual Meeting of Stockholders of 10x Genomics, Inc. and call this meeting to order. I'm Serge Saxonov, Co-Founder, Chief Executive Officer and a member of the Board of Directors of 10x Genomics, and I will act as Chairperson of the meeting. Adam Taich, our Chief Financial Officer; Randy Wu, our General Counsel; and Cassie Corneau, 10x's Senior Director, Investor Relations and Strategic Finance; James Bryant, 10x's Senior Director, Corporate Legal; and Atticus Belcher from 10x's legal team join me in welcoming you today. James will act as Secretary of the meeting.

I would also like to welcome the members of our Board of Directors who are present at today's meeting. I'm also pleased to welcome Casey Hayes, a representative of Ernst & Young, our external auditing firm, who is here to answer any appropriate questions. In addition, I'd like to welcome John Lundberg, a representative of Equiniti Trust Company, LLC, our transfer agent, who has been appointed to act as our Inspector of Election. Mr. Lundberg has signed an oath of office, which will be filed with the minutes of this meeting. Please note that this meeting is being recorded, and a replay of the audio cast will be posted to the Investor Relations section of our website at investors.10xgenomics.com as soon as practical.